2025 Annual Meeting Meeting: The Online Experience

Agenda

The Online Experience Opens June 1, 2025!

  • Learn from experts in the field of breast surgery
  • A broad array of clinical and practical topics
  • All General Session content in an engaging, user-friendly format
  • Access innovative scientific and clinical concepts
  • Self-paced, in-depth learning
  • Earn up to 22.25 AMA PRA Category 1 Credit(s)™
Online Experience Overview

Coding, Reimbursement, and Quality Symposium

Moderators: Richard Fine, MD, FACS; Walton Taylor, MD, FACS
  • Coding and Reimbursement
    Linda Han, MD, FACS, FSSO
  • Coding and Reimbursement Panel Q&A
    Richard Fine, MD, FACS; Linda Han, MD, FACS, FSSO; Walton Taylor, MD, FACS
  • EUSOMA Quality Indicators
    Isabel Rubio, MD, PhD
  • NAPBC Quality Measures and Standards
    Paul Baron, MD, FACS
  • Q&A

Scientific Oral Presentations 1

Moderators: Sarah Blair, MD, FACS; Megan Miller, MD, FACS
  • Welcome and Introduction
    Sarah Blair, MD, FACS; Megan Miller, MD, FACS
  • Validation of the Performance of the Novel Prognostic Staging System for Overall Survival in De Novo Metastatic Breast Cancer and Demonstration of Performance for Cancer Specific Outcomes
    Christopher Vetter, MD
  • Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial
    Rita Mukhtar, MD, FACS
  • From Podium to PubMed: Successful Manuscript Publication of Breast Surgical Oncology Presentations at National Meetings from 2017–2022
    Margaret Summerside
  • Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial
    Julie Van Hassel, MD
  • Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
    Dennis Holmes, MD, FACS

Multidisciplinary Communication in the Era of De-escalation

Moderators: Giacomo Montagna, MD, MPH, FACS; Alyssa Throckmorton, MD, FACS
  • Welcome and Introduction
    Giacomo Montagna, MD, MPH, FACS; Alyssa Throckmorton, MD, FACS
  • What to Omit and When: Management of ER+ HER- Axillary Disease
    Rachel McCaffrey, MD, FACS
  • CDK4/6 Inhibition: What Do Surgeons Need to Know?
    Austin Williams, MD, MSEd, FACS
  • Omission of Radiation With Nodal pCR to Neoadjuvant Chemotherapy
    Jennifer Plichta, MD, MS, FACS
  • Omission of Surgery After Neoadjuvant Chemotherapy
    Isabel Rubio, MD, PhD
  • Q&A

Outside the Clinical Trials

Moderators: Richard Barth, Jr., MD, FACS; Stephanie Serres, MD, PhD
  • Welcome and Introduction
    Richard Barth, Jr., MD, FACS; Stephanie Serres, MD, PhD
  • Evidence for Complementary and Alternative Medicine (CAM)
    Theresa Schwartz, MD, MS, FACS
  • Ethics of Complementary and Alternative Medicine (CAM)
    Jennifer Fieber, MD, FACS
  • Spirituality and Religion
    Katherina Calvillo, MD, FACS
  • Q&A

Debate: DCIS Should Be Managed With Observation Alone

Moderators: Kari Kansal, MD, FACS; Alastair Thompson, MD, BSc(Hons), MB ChB, MD, FRCSEd FACS
  • Welcome and Introduction
    Kari Kansal, MD, FACS; Alastair Thompson, MD, BSc(Hons), MB ChB, MD, FRCSEd FACS
  • Pro: Observation for DCIS
    E. Shelley Hwang, MD, MPH, FACS
  • Con: Surgical Resection for DCIS
    Kimberly Van Zee, MS, MD, FACS
  • Take Home Message for DCIS Management in 2025
    Anna Weiss, MD, FACS

Debate: Contralateral Prophylactic Mastectomy

Moderators: Rachel Greenup, MD, MPH, FACS; Paige Teller, MD, FACS
  • Welcome and Introduction
    Rachel Greenup, MD, MPH, FACS; Paige Teller, MD, FACS
  • Pro Contralateral Prophylactic Mastectomy
    Lee Wilke, MD, FACS
  • Against Contralateral Prophylactic Mastectomy
    Funda Meric-Bernstam, MD, FACS
  • Summary and Best Practice for Contralateral Prophylactic Mastectomy in 2025
    Laura Dominici, MD, FACS
  • International Perspective on Contralateral Prophylactic Mastectomy
    Marie Jeanne Vrancken Peeters, MD, PhD

Invasive Lobular Breast Cancer: It Isn’t Just Ductal

Moderators: Anna Beck, MD; Lillian Erdahl, MD, FACS
  • Welcome and Introduction
    Anna Beck, MD; Lillian Erdahl, MD, FACS
  • Welcome and Introduction
    Evelyn Carroll, MD
  • Genetics and Invasive Lobular Carcinoma
    Lauren Gamble, MD
  • Surgical Management of the Breast in Invasive Lobular Carcinoma
    Rita Mukhtar, MD, FACS
  • Surgical Management of the Axilla in Invasive Lobular Carcinoma
    Michael Cassidy, MD, FACS
  • Neoadjuvant Therapy for Invasive Lobular Carcinoma
    Meghan Flanagan, MD, MPH, FACS
  • Q&A

“How I Do It” Videos

Moderators: Katrina Mitchell, MD, IBCLC, FACS; Courtney Vito, MD, FACS

Debate: Is Breast Conservation Safer Than Mastectomy?

Moderators: Christine Laronga, MD, FACS; Jennifer Tonneson, MD, FACS
  • Welcome and Introduction
    Christine Laronga, MD, FACS; Jennifer Tonneson, MD, FACS
  • Pro Mastectomy
    Kandace McGuire, MD, FACS
  • Pro Breast Conservation Therapy
    Mahmoud El-Tamer, MD, FACS
  • Summary and Best Practice of Breast Conservation vs Mastectomy in 2025
    Stephanie Downs-Canner, MD, FACS
  • Ethics of Shared Decision Making in Era as Data Evolve
    Puneet Singh, MD, FACS

Keynote Address

  • Keynote Address Introduction
    Judy Boughey, MD, FACS
  • Keynote Address: “Re-imagining Stage 0 and 1 Breast Cancer”
    Bruce Mann, MBBS, PhD, FRACS

Maximizing Your Breast Surgery Practice

Moderators: Lana Shikhman, MD, FACS; Jennifer Tseng, MD, FACS
  • Welcome and Introduction
    Lana Shikhman, MD, FACS; Jennifer Tseng, MD, FACS
  • Optimizing APPs in a Successful Breast Practice
    Kimberly Hoskins, NP; Melissa Pilewskie, MD, FACS
  • Quality of Care: Institutional and Individual Surgeon Assessments
    Richard White, Jr., MD, FACS
  • Industry Relationships: Navigating the Value and Challenges
    Sarah McLaughlin, MD, FACS
  • Q&A

Scientific Oral Presentations 2

Moderators: Catherine Parker, MD, FACS; Mediget Teshome, MD, MPH, FACS
  • Welcome and Introduction
    Catherine Parker, MD, FACS; Mediget Teshome, MD, MPH, FACS
  • Margin Width and Local Recurrence in the NRG Oncology/NSABP B-35 DCIS Lumpectomy Trial
    Irene Wapnir, MD
  • 90 days of Pre-Operative Endocrine Therapy Informs Patient and Physician Preference for Radiation Therapy: Primary results from the Pre-Operative Window of Endocrine Therapy to Inform Radiation Therapy Decisions (POWER) Trial
    Shayna Showalter, MD, FACS
  • Ultrasound Guided Intratumoral Delivery of Immunotherapy in Breast Cancer
    Camille Baumrucker, MD
  • Evaluating the Effect of a Multidisciplinary Breast Cancer Clinic on Time to Treatment at an Urban, Safety Net Hospital
    Anna Kobzeva-Herzog, MD
  • Impact of Quality Improvement Interventions on Biopsy to Treatment Time in Breast Cancer: Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers
    Danielle Thompson, MD
  • Surgeon Recommendation Drives Receipt of Sentinel Lymph Node Biopsy in Women 70 and Over
    Heather Neuman, MD
  • A Prospective, Randomized Controlled Study to Evaluate Efficacy of Argon Beam Coagulation Versus Conventional Electrosurgical Coagulation for Cutting and Coagulation During Mastectomy with Reconstruction
    Stacey Cartner, MD

Cultural Competencies in Breast Surgery

Moderators: Alaina Geary, MD, MHPE; Lauren Postlewait, MD, FACS
  • Welcome and Introduction
    Alaina Geary, MD, MHPE; Lauren Postlewait, MD, FACS
  • Cultural Awareness in the Care of Breast Cancer Patients
    Olga Kantor, MD, FACS
  • Screening for Breast Cancer in the Transgender Population
    Evelyn Carroll, MD
  • Management of High-Risk and Breast Cancer in the Transgender Population
    Chandler Cortina, MD, MS, FSSO, FACS
  • Racial Disparities in Access and Outcomes for Women with Breast Cancer
    Shon Black, MD, FACS, FSSO
  • Financial Toxicity
    Mary Gemignani, MD, MPH, FACS
  • Q&A

Quickshots Presentations

Moderators: Carla Fisher, MD, MBA, FACS; Marissa Howard-McNatt, MD, FACS
  • Welcome and Introduction
    Carla Fisher, MD, MBA, FACS; Marissa Howard-McNatt, MD, FACS
  • Neighborhood-Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation
    Priyanka Parmar, MD
  • Second Opinions, Same Standards: Time to Treatment for Breast Cancers Diagnosed Externally
    Pooja Varman, MD, MS
  • Association of Surgeon Volume with Adherence to American Society of Breast Surgeons Surgical Quality Measures
    Kelley Chan, MD, MS
  • Evaluating the Impact of a Surgeon-Led Ductal Carcinoma in Situ Program on Endocrine Therapy Uptake
    Monika Masanam, MD
  • Impact of Pathologic Complete Response on Local-Regional Recurrence in Patients Undergoing Neoadjuvant Chemotherapy and Breast Conserving Surgery
    Victoria Huynh, MD
  • Low Complication Rates After Invasive Procedures on the Lactating Breast in Patients Treated for Breast Cancer During Pregnancy
    Jennifer Chen, MD
  • Pitfalls of Nipple-Sparing Mastectomy: Recurrences are in the Nipple and Axilla
    Swetha Duraiswamy, MD
  • Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors: A Feasibility Study
    Ellery Reason

Hoag Hospital Surgical Innovation Forum: Innovative Surgical Techniques

Moderators: Julie Billar, MD; Abhishek Chatterjee, MD, MBA, FACS
  • Welcome and Introduction
    Julie Billar, MD; Abhishek Chatterjee, MD, MBA, FACS
  • Robotic Mastectomy
    Mara Piltin, DO, FACS
  • Lymphovenous Bypass and Lymph Node Transfer
    Zahraa Al-Hilli, MD, MBA, FACS, FRCSI
  • Extreme Oncoplasty
    Kristalyn Gallagher, DO, FACOS, FACS
  • Minimally Invasive Vacuum Assisted Excision for Small Cancers
    Stuart McIntosh, MBChB, PhD
  • Advances in Breast Reconstruction
    Scott Hollenbeck, MD, FACS
  • Q&A

Scientific Oral Presentations 3

Moderators: Leslie Montgomery, MD, FACS, FSSO; Candice Sauder, MD, MEd, FACS
  • Welcome and Introduction
    Leslie Montgomery, MD, FACS, FSSO; Candice Sauder, MD, MEd, FACS
  • Reducing Seroma Formation After Mastectomy by Performing Flap Fixation Techniques: A Multi-Center, Double-Blind Randomized Controlled Trial Including Technical Aspects and Economic Evaluation
    Merel Spiekerman van Weezelenburg, MD
  • Association of Margin Width and Local Recurrence Following Mastectomy for DCIS
    Amanda Nash, MD
  • Pre-Treatment Tumor Collagen is Associated with Triple-Negative Breast Cancer Pathological Response to Chemo-Immunotherapy
    Mackenzie Jones, MD
  • Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial
    Mandeep Kaur
  • Survival Differences Persist Despite Less Intensive Treatment for Women Diagnosed with Early-Stage Breast Cancer via Active Screening
    Melissa Edwards, BSc, MBChB, PGDip, PhD, FRACS
  • A Prospective, Multi-Center, Randomized, Double-Arm Clinical Trial To Assess the Positive Margin Rate of Breast-Conserving Surgery With or Without the Aid of an Intraoperative Optical Coherence Tomography System
    Alastair Thompson, MD, BSc(Hons), MB ChB, MD, FRCSEd FACS

2024 Best Papers

  • Welcome and Introduction
    Kari Rosenkranz, MD, FACS
  • 2024 Best Papers
    Helen Pass, MD, FACS

Presidential Address

  • Presidential Address Introduction
    Michael Berry, MD, FACS
  • Presidential Address
    Judy Boughey, MD, FACS

Multidisciplinary Care and Tumor Biology

Moderators: Elizabeth Mittendorf, MD, PhD, FACS; Jamie Wagner, DO, MBA, FACOS, FACS
  • Welcome and Introduction
    Elizabeth Mittendorf, MD, PhD, FACS; Jamie Wagner, DO, MBA, FACOS, FACS
  • Debate: All Patients Should Be Treated With Neoadjuvant Systemic Therapy Followed by Surgery
    Laura Esserman, MD, MBA, FACS
  • Standard of Care Remains Upfront Surgery Followed by Systemic Therapy
    Armando Giuliano, MD, FACS
  • Optimal Management Strategy in 2025
    Mediget Teshome, MD, MPH, FACS
  • Indications and Benefits of Immunotherapy: Triple-negative Breast Cancer and Luminal Breast Cancer
    Julia Tchou, MD, PhD, FACS
  • Perioperative Management of Patients on Immunotherapy: Important Information for Surgeons and Anethesia
    Tina Hieken, MD, FACS
  • Q&A
  • Debate: Axillary Lymph Node Dissection Is Recommended After Neoadjuvant Chemotherapy for Residual Node Positive Disease
    Marie Jeanne Vrancken Peeters, MD, PhD
  • Radiation Therapy Can Replace Axillary Lymph Node Dissection for Residual Node Positive Disease After Neoadjuvant Chemotherapy
    Walter Weber, MD
  • Management of Residual Node Positive Disease in 2025 While We Await More Data
    Kelly Hunt, MD, FACS
  • Q&A

Your ASBrS: We Are Your Society

  • Annual Business Meeting
  • Salary Survey
    Eric Manahan, MD, MBA, FACS
  • 2024-2025 ASBrS Year in Review
    Judy Boughey, MD, FACS
  • Changes in Breast Surgical Oncology Fellowship Training Experience Over the Years
    Andrea Madrigrano, MD
  • Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants and Program Directors Preferences Regarding In-Person vs Virtual Interviews
    Jennifer Plichta, MD, MS, FACS
  • Oral Presentation and Poster Presentation Awards
    Sarah Blair, MD, FACS
  • Recognition of Newly Certified Individuals
    Michele Carpenter, MD, FACS; Nicole Demos, PA-C
  • Meet the ASBrS Board and Staff and Awards Presentation

Management of Unique Populations

Moderators: Lesly Dossett, MD, MPH, FACS; Susan Kesmodel, MD, FACS
  • Welcome and Introduction
    Lesly Dossett, MD, MPH, FACS; Susan Kesmodel, MD, FACS
  • Elderly: When to Stop Screening, Omission of Surgery (endocrine therapy alone vs cyroblation)
    Ingrid Lizarraga, MBBS, FACS
  • Pregnant Patient and Pregnancy After Breast Cancer
    Jacqueline Jeruss, MD, PhD, FACS
  • Recurrent Breast Cancer
    Mary Mrdutt, MD, MS, FACS
  • Adolescent and Young Adults: Management and Survivorship
    Candice Sauder, MD, MEd, FACS
  • Male Breast Cancer
    Lucy De La Cruz, MD, FACS
  • Q&A

Communicating With Our Patients

Moderators: Vivian Bea, MD, MBS, FACS; Jillian Smith, MD, MPH, FACS
  • Welcome and Introduction
    Vivian Bea, MD, MBS, FACS; Jillian Smith, MD, MPH, FACS
  • Patient Perspective
    Amanda Echalaz, BMus Hons
  • Empathy is Not as Easy as It Sounds
    Rakhshanda Layeequr Rahman, MD, FACS
  • Shared Decision-Making Tools
    Julie Margenthaler, MD, FACS
  • Integrating Patient-reported Outcomes Into Patient Counseling
    Sarah Tevis, MD, FACS
  • Q&A

Axillary Management in 2025 and Beyond

Moderators: Steven Cai, MD, FACS; Jennifer Plichta, MD, MS, FACS
  • Welcome and Introduction
    Steven Cai, MD, FACS; Jennifer Plichta, MD, MS, FACS
  • Axillary Surgery in the Clinically Negative Axilla in Patients Undergoing Upfront Surgery?
    Oluwadamilola “Lola” Fayanju, MD, MA, MPHS, FACS
  • Axillary Surgery for Patients With Ultrasound Biopsy Positive Node(s) [cN1 disease] Undergoing Upfront Surgery
    Akiko Chiba, MD, FACS
  • Axillary Management of 1-2 Positive Nodes After Treatment With Neoadjuvant Endocrine Therapy
    Arielle Stafford, MD, FACS
  • Is Axillary Lymph Node Dissection Required in cN2/N3 Disease with Imaging Response After Neoadjuvant Systemic Therapy?
    Roshni Rao, MD, FACS
  • Omission of Radiation in cN+ Disease with Response to Neoadjuvant Systemic Therapy
    Bruce Haffty, MD FACR FASTRO FASCO
  • Q&A

ASBrS Benign Breast Disease Guidelines

Moderators: Helen Pass, MD, FACS; Katharine Yao, MD, FACS
  • Welcome and Introduction
    Helen Pass, MD, FACS; Katharine Yao, MD, FACS
  • Fibroadenoma and Fibroepithelial Lesions and Benign Phyllodes
    Lorraine Tafra, MD, FACS
  • Idiopathic Granulomatous Mastitis, Lactational Mastitis and Squamous Metaplasia of the Lactiferous Ducts
    Katrina Mitchell, MD, IBCLC, FACS
  • Atypia and Lobular Carcinoma in Situ
    Tari King, MD, FACS, FSSO
  • Other Benign Lesions
    Amanda Amin, MD, MS, FACS
  • Q&A

Key Updates From National and International Meetings

Moderators: Toan Nguyen, MD, FACS; Shayna Showalter, MD, FACS
  • Welcome and Introduction
    Toan Nguyen, MD, FACS; Shayna Showalter, MD, FACS
  • ASCO
    Lisa Newman, MD, MPH, FACS, FASCO, FSSO
  • San Antonio
    Henry Kuerer, MD, PhD, FACS
  • ASTRO
    Bruce Haffty, MD FACR FASTRO FASCO
  • St Gallen
    Walter Weber, MD
  • The Lancet Breast Cancer Commission
    Stuart McIntosh, MBChB, PhD
  • Q&A

Closing Ceremony: Vision of ASBrS for 2025-2026

Presenters: Michael Berry, MD, FACS; Judy Boughey, MD, FACS
© 2025 The American Society of Breast Surgeons
7067 Columbia Gateway Drive, Suite 290, Columbia, MD 21046
Email: contact@breastsurgeons.org    Phone: 410-381-9500 or 877-992-5470    Fax: 410-381-9512
Privacy Policy • Terms of Use